Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Piscitelli

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Pharmacokinetics|February 29, 2024
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin CoadministrationJoseph Piscitelli, Micaela B Reddy, Lance Wollenberg, et al.
Therapeutic Drug Monitoring|January 16, 2023
Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic ApproachJoseph Piscitelli, Mina Nikanjam, Edmund V Capparelli, et al.
Targeted Oncology|February 25, 2025
Dose Optimization of Elranatamab to Mitigate the Risk of Cytokine Release Syndrome in Patients with Multiple MyelomaMohamed Elmeliegy, Andrea Viqueira, Erik Vandendries, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2022
A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream InfectionsCourtney L Luterbach, Hongqiang Qiu, Patrick O Hanafin, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Pharmacokinetics|February 29, 2024
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin CoadministrationJoseph Piscitelli, Micaela B Reddy, Lance Wollenberg, et al.
Therapeutic Drug Monitoring|January 16, 2023
Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic ApproachJoseph Piscitelli, Mina Nikanjam, Edmund V Capparelli, et al.
Targeted Oncology|February 25, 2025
Dose Optimization of Elranatamab to Mitigate the Risk of Cytokine Release Syndrome in Patients with Multiple MyelomaMohamed Elmeliegy, Andrea Viqueira, Erik Vandendries, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2022
A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream InfectionsCourtney L Luterbach, Hongqiang Qiu, Patrick O Hanafin, et al.
Pageof 2